With philanthropic support, our biomedical researchers will continue contributing to the world’s fight against cancer.
We are engaged in cutting-edge experimental therapeutics—an effort to design novel medications tailored to individual patients.
Our researchers are developing biomarkers—molecular fingerprints—to detect cancer at its earliest stages without surgery or biopsy.
We are investigating nanoscale therapies to precisely deliver targeted treatments to tumors while preserving healthy tissues.
Our expert team is developing gene therapies to undermine cancer with personalized treatments and targeted strikes on cancer cells.